Doctronic, an AI doctor platform offering free 24/7 anonymous consults, has raised $40M in Series B funding co-led by Abstract Ventures and Lightspeed Venture Partners. The platform provides personalized assessments, SOAP notes, triage, and escalates to $39 video visits with licensed US physicians, plus Utah-specific AI prescription refills. The capital will fuel expansion of AI prescription capabilities and partnerships with health systems and payers.
AI Primary Care Funding Surges
The raise follows K Health securing $50M Series C in February 2026, bringing its total to $439M. Doctronic's model stands out with free anonymous AI entry and first-in-nation autonomous prescription renewals in Utah for 190+ medications. This timing aligns with AI capturing 55% of health tech VC in 2025 per Bessemer.
Primary Care Access Crisis Deepens
100M Americans lack reliable primary care access, with average waits reaching 31 days for a doctor visit. Non-compliance costs the US $100B annually, exacerbated by 80% of pharmacy activity being refills. Current solutions fail to deliver 24/7 anonymous triage without persistent health history or seamless human escalation.
Free AI Consults Drive Adoption
Doctronic's AI generates diagnoses, treatment plans, and SOAP notes with 99.2% agreement to board-certified clinicians across a 500-case study. It maintains persistent health records across sessions and escalates complex cases to human doctors. Unlike K Health's subscription model or Ada Health's $120M-funded triage tool, Doctronic offers unlimited free AI chats leading to one-off $39 visits.
Utah Pilot Enables Autonomous Refills
In December 2025, Doctronic launched the first US-approved AI prescription renewal program in Utah under a regulatory sandbox, covering routine refills for chronic conditions. This positions it ahead of symptom checkers like Ada Health, which lack prescription support. The platform is HIPAA-compliant with zero hallucinations in benchmarks.
Tier-1 VCs Bet on Regulated AI
Co-leads Abstract Ventures and Lightspeed bring AI-health conviction, with Lightspeed backing Abridge and Anthropic, and Abstract investing in Max AI. Existing backers Union Square Ventures and Tusk Venture Partners add regulatory expertise seen in Ro and Wheel. This mix signals validation for Doctronic's path through FDA scrutiny amid rapid scaling to $65M total raised.
As Matt Pavelle, co-CEO, noted:
"Health systems see us as infrastructure, the digital front door that routes their patients efficiently and keeps care in-network. Payers see us as unlimited primary care at a predictable cost."
Conversational AI Market Explodes
The conversational AI in healthcare market stands at $17.2B in 2025, projected to reach $169.5B by 2035 at 26% CAGR per Future Market Insights. Broader AI healthcare hits $50.7B growing at 38.9% CAGR. Trends shift from AI scribes to patient-facing agents amid provider shortages.
Surgeons and Unicorns Lead Team
Co-founders Matt Pavelle, founding CTO of unicorn Moda Operandi, and Dr. Adam Oskowitz, UCSF vascular surgeon, combine tech scaling with clinical depth. Pavelle's multiple exits and Oskowitz's practicing MD status ensure safety in AI decisions. The team includes ex-Flatiron DS leads and growth experts from GoodRx.
Pediatrics and Payer Deals Ahead
Doctronic plans pediatrics expansion, health system integrations as a 'digital front door,' and talks with other states for AI refills per MobiHealthNews. Recent hires target partnerships post-24M consults and 15x ARR growth. Projected $10M+ revenue this year supports national rollout.